Minister of Health for KSA Unveils Boston Oncology and KFMC’s Groundbreaking Cell & Gene Therapy Program In his opening address to the Global Health Exhibition - ملتقى الصحة العالمي , the Minister of Health, H.E. Fahd bin Abdurrahman Al-Jalajel, announced a pioneering partnership between Boston Oncology and KFMC to bring advanced cell & gene therapy solutions to Saudi Arabia. This transformative agreement will localize innovative therapies, expand patient access, attract foreign investment, and reduce reliance on imported treatments and the need for patients to seek care abroad—advancing key healthcare goals under the Kingdom’s Vision 2030. We are proud to collaborate with KFMC on this bold initiative, building the infrastructure needed to deliver world-class care and positioning the Kingdom as a leader in therapeutic innovation. #GHE24 #DigitalHealth #KFMC #KSA #Vision2030 #GlobalHealthExhibition #HealthcareInnovation #InvestInHealth #CellAndGeneTherapy
A 3 billion Riyal agreement between King Fahad Medical City - KFMC and Boston Oncology to establish an advanced manufacturing unit (GMP Facility) to produce immunotherapy with programmed T cells using a clean closed system during the #GHE24 #InvestInHealth #Riyadh_Second_Health_Cluster